Evidence map›Paper›PMID 25436983›Full record

ArticleOncotarget2015

EphrinB1: novel microtubule associated protein whose expression affects taxane sensitivity.

Paul L Colbert, Daniel W Vermeer, Bryant G Wieking, John H Lee, Paola D Vermeer

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Elucidating the role ofFrontiers in immunology · 2025
    Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Paul L ColbertCancer Biology Research Center, Sanford Research, Sioux Falls, South Dakota, USA.
Daniel W VermeerCancer Biology Research Center, Sanford Research, Sioux Falls, South Dakota, USA.
Bryant G WiekingCancer Biology Research Center, Sanford Research, Sioux Falls, South Dakota, USA.
John H LeeCancer Biology Research Center, Sanford Research, Sioux Falls, South Dakota, USA.
Paola D VermeerCancer Biology Research Center, Sanford Research, Sioux Falls, South Dakota, USA.
Sanford Research · US

Funding

The Impact of PD-1 Inhibition on Immune-Response to ChemoradiotherapyP20GM103548 · NIGMS · SANFORD RESEARCH/USD · PI MISKIMINS, W KEITH · 2012 to 2020
$20.8M
Mechanisms of invasion for an HIV related head and neck cancerR01DE018386 · NIDCR · UNIVERSITY OF IOWA · PI LEE, JOHN H · 2007 to 2011
$1.9M
NIDCR NIH HHS R01 DE018386NIGMS NIH HHS 8P20GM103548NIGMS NIH HHS P20 GM103548
6 · The paper itself

Abstract

Microtubules (MTs) are components of the cytoskeleton made up of polymerized alpha and beta tubulin dimers. MT structure and function must be maintained throughout the cell cycle to ensure proper execution of mitosis and cellular homeostasis. The protein tyrosine phosphatase, PTPN13, localizes to distinct compartments during mitosis and cytokinesis. We have previously demonstrated that the HPV16 E6 oncoprotein binds PTPN13 and leads to its degradation. Thus, we speculated that HPV infection may affect cellular proliferation by altering the localization of a PTPN13 phosphatase substrate, EphrinB1, during mitosis. Here we report that EphrinB1 co-localizes with MTs during all phases of the cell cycle. Specifically, a cleaved, unphosphorylated EphrinB1 fragment directly binds tubulin, while its phosphorylated form lacks MT binding capacity. These findings suggest that EphrinB1 is a novel microtubule associated protein (MAP). Importantly, we show that in the context of HPV16 E6 expression, EphrinB1 affects taxane response in vitro. We speculate that this reflects PTPN13's modulation of EphrinB1 phosphorylation and suggest that EphrinB1 is an important contributor to taxane sensitivity/resistance phenotypes in epithelial cancers. Thus, HPV infection or functional mutations of PTPN13 in non-viral cancers may predict taxane sensitivity.

Indexed as

AnimalsAntineoplastic AgentsBridged-Ring CompoundsCarcinoma, Squamous CellCell LineCell Line, TumorCell SurvivalDose-Response Relationship, DrugEphrin-B1Head and Neck NeoplasmsHEK293 CellsHuman papillomavirus 6HumansImmunoblottingMCF-7 CellsMice, Inbred C57BLAntineoplastic AgentsBridged-Ring CompoundsE6 protein, Human papillomavirus type 16Ephrin-B1Microtubule-Associated ProteinsOncogene Proteins, ViralPaclitaxelRepressor ProteinstaxaneTaxoids

Identifiers

PMID25436983
PMCPMC4359267
OpenAlexW1836231645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.